Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Anne Fuhlbrigge

Concepts (429)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Asthma
98
2025
1924
9.460
 Why?
Anti-Asthmatic Agents
28
2025
273
3.320
 Why?
Adrenal Cortex Hormones
28
2025
505
3.290
 Why?
Forced Expiratory Volume
19
2019
488
1.540
 Why?
Pulmonary Disease, Chronic Obstructive
11
2022
1052
1.340
 Why?
Severity of Illness Index
20
2020
2939
0.960
 Why?
Administration, Inhalation
25
2025
597
0.940
 Why?
Anti-Inflammatory Agents
10
2016
482
0.860
 Why?
Albuterol
5
2015
75
0.830
 Why?
Bronchodilator Agents
12
2016
196
0.820
 Why?
Lung Transplantation
10
2017
325
0.800
 Why?
Budesonide
14
2016
56
0.790
 Why?
Remote Consultation
4
2025
63
0.740
 Why?
Nedocromil
11
2016
23
0.710
 Why?
Humans
129
2025
143876
0.690
 Why?
Nasal Polyps
1
2021
62
0.680
 Why?
Self Report
3
2023
878
0.670
 Why?
Pharmacogenetics
2
2015
169
0.660
 Why?
Endpoint Determination
2
2020
80
0.660
 Why?
Food Hypersensitivity
1
2022
189
0.600
 Why?
Sinusitis
1
2021
239
0.580
 Why?
Virus Diseases
1
2021
218
0.570
 Why?
Lung
7
2019
4119
0.570
 Why?
Glucocorticoids
4
2022
542
0.560
 Why?
Physicians
2
2021
940
0.560
 Why?
Symptom Assessment
1
2019
133
0.550
 Why?
Hospitalization
13
2020
2317
0.540
 Why?
Sleep Apnea, Obstructive
1
2021
320
0.510
 Why?
Androstadienes
3
2012
74
0.510
 Why?
Bone Density
2
2014
503
0.490
 Why?
Child
53
2022
22784
0.490
 Why?
Disease Progression
14
2020
2862
0.490
 Why?
Oxygen Inhalation Therapy
4
2020
184
0.480
 Why?
Managed Care Programs
8
2008
140
0.480
 Why?
Male
82
2025
71701
0.470
 Why?
Precision Medicine
1
2020
446
0.460
 Why?
Emergency Service, Hospital
9
2013
2274
0.460
 Why?
Adult
47
2025
40115
0.460
 Why?
Adrenergic beta-2 Receptor Agonists
4
2020
27
0.440
 Why?
Female
81
2025
77455
0.440
 Why?
Cost Savings
1
2015
86
0.440
 Why?
Patient Reported Outcome Measures
1
2018
463
0.420
 Why?
Practice Patterns, Physicians'
7
2020
1362
0.420
 Why?
Peak Expiratory Flow Rate
2
2011
25
0.400
 Why?
Cost-Benefit Analysis
7
2022
624
0.400
 Why?
Middle Aged
40
2025
35428
0.390
 Why?
Phenotype
6
2025
3210
0.380
 Why?
Comorbidity
4
2021
1681
0.360
 Why?
Academic Medical Centers
3
2024
535
0.350
 Why?
Surveys and Questionnaires
14
2022
6037
0.330
 Why?
Adolescent
37
2019
22529
0.330
 Why?
Medical Records Systems, Computerized
3
2008
96
0.330
 Why?
Administration, Oral
6
2021
842
0.330
 Why?
Mentors
1
2012
215
0.320
 Why?
Quality of Life
12
2023
3085
0.320
 Why?
Respiratory Function Tests
10
2015
562
0.320
 Why?
United States
23
2022
15592
0.310
 Why?
Interprofessional Relations
3
2021
283
0.300
 Why?
Faculty, Medical
1
2012
297
0.300
 Why?
Treatment Outcome
16
2025
11390
0.300
 Why?
Child, Preschool
31
2016
11782
0.300
 Why?
Spirometry
8
2020
263
0.300
 Why?
Child Development
1
2014
507
0.290
 Why?
Group Practice
1
2008
6
0.280
 Why?
Anti-Allergic Agents
2
2008
44
0.280
 Why?
Oxygen
3
2018
998
0.280
 Why?
Computer Simulation
1
2012
1028
0.270
 Why?
Aged
22
2022
25376
0.270
 Why?
Dyspnea
3
2022
259
0.260
 Why?
Drug Utilization
4
2005
166
0.250
 Why?
Randomized Controlled Trials as Topic
8
2020
1675
0.250
 Why?
Primary Health Care
5
2025
1780
0.240
 Why?
Primary Graft Dysfunction
2
2017
34
0.240
 Why?
Quality Assurance, Health Care
1
2008
322
0.240
 Why?
Follow-Up Studies
17
2017
5319
0.240
 Why?
Bronchiolitis Obliterans
3
2017
64
0.230
 Why?
Gift Giving
1
2005
9
0.230
 Why?
Respiratory Sounds
1
2006
110
0.230
 Why?
Diagnostic Techniques, Respiratory System
1
2005
5
0.230
 Why?
Allergists
2
2022
11
0.230
 Why?
Genetic Testing
1
2008
474
0.220
 Why?
Delivery of Health Care
2
2021
954
0.220
 Why?
Medication Adherence
2
2023
515
0.210
 Why?
Cohort Studies
14
2013
5898
0.210
 Why?
Retrospective Studies
18
2024
16797
0.210
 Why?
Specialization
2
2025
135
0.210
 Why?
Natural Language Processing
1
2025
103
0.200
 Why?
Time Factors
10
2020
7042
0.200
 Why?
Massachusetts
5
2016
179
0.200
 Why?
Leadership
2
2022
397
0.200
 Why?
Antibodies, Monoclonal
2
2008
1477
0.200
 Why?
Medicine
1
2025
125
0.200
 Why?
Rhinitis, Allergic, Perennial
1
2003
22
0.190
 Why?
Genetic Variation
1
2008
1010
0.190
 Why?
Steroids
8
2011
165
0.190
 Why?
Recurrence
5
2013
1122
0.190
 Why?
Health Status
1
2008
824
0.190
 Why?
Genetic Predisposition to Disease
2
2025
2423
0.190
 Why?
Predictive Value of Tests
9
2012
2087
0.190
 Why?
Beclomethasone
1
2022
9
0.180
 Why?
Multicenter Studies as Topic
4
2018
390
0.180
 Why?
Young Adult
11
2019
13998
0.180
 Why?
Prevalence
4
2022
2832
0.180
 Why?
Models, Theoretical
4
2007
588
0.180
 Why?
Tiotropium Bromide
2
2018
5
0.180
 Why?
Desensitization, Immunologic
1
2022
94
0.170
 Why?
Nebulizers and Vaporizers
2
2020
68
0.170
 Why?
Biomarkers
3
2021
4244
0.170
 Why?
Social Class
2
2022
273
0.170
 Why?
Patient Preference
1
2023
212
0.170
 Why?
Churg-Strauss Syndrome
1
2020
27
0.160
 Why?
Bronchoconstriction
3
2011
28
0.160
 Why?
Pulmonologists
1
2020
14
0.160
 Why?
Capacity Building
1
2021
59
0.160
 Why?
Granulomatosis with Polyangiitis
1
2020
47
0.160
 Why?
Muscarinic Antagonists
1
2020
30
0.160
 Why?
Agammaglobulinemia
1
2020
36
0.160
 Why?
Physician-Patient Relations
2
2021
589
0.150
 Why?
Electronic Health Records
2
2025
1167
0.150
 Why?
Practice Guidelines as Topic
5
2020
1562
0.150
 Why?
Risk Factors
12
2018
10673
0.150
 Why?
Air Pollution, Indoor
2
2002
183
0.150
 Why?
Treatment Adherence and Compliance
1
2019
27
0.150
 Why?
Exercise Test
1
2022
624
0.140
 Why?
Receptors, IgE
2
2009
44
0.140
 Why?
Prognosis
8
2017
4163
0.140
 Why?
Vitamin D
2
2012
401
0.140
 Why?
Allergens
1
2021
408
0.130
 Why?
Fossil Fuels
1
1997
10
0.130
 Why?
Hypersensitivity
1
2020
258
0.130
 Why?
Alemtuzumab
1
2017
15
0.130
 Why?
Photopheresis
1
2017
9
0.130
 Why?
Biological Products
1
2020
246
0.130
 Why?
Drug Prescriptions
2
2011
275
0.130
 Why?
Respiration
1
2017
209
0.130
 Why?
Emergency Medical Services
2
2007
688
0.130
 Why?
Respiration Disorders
1
1997
79
0.130
 Why?
Physicians, Primary Care
3
2021
224
0.120
 Why?
Drug Combinations
3
2012
376
0.120
 Why?
Statistics, Nonparametric
1
2017
434
0.120
 Why?
Drug Therapy, Combination
5
2020
1058
0.120
 Why?
Immunomodulation
1
2017
102
0.120
 Why?
Drug Monitoring
1
2020
397
0.120
 Why?
Socioeconomic Factors
4
2022
1326
0.120
 Why?
Breath Tests
2
2008
77
0.120
 Why?
Tobacco Smoke Pollution
2
2010
238
0.120
 Why?
Scopolamine Derivatives
1
2015
3
0.120
 Why?
Aged, 80 and over
6
2019
8077
0.120
 Why?
Patient Admission
1
2018
203
0.120
 Why?
Embolism, Fat
1
2015
11
0.120
 Why?
Immunoglobulin G
1
2020
898
0.120
 Why?
Cholinergic Antagonists
1
2015
24
0.120
 Why?
Transplants
1
2015
39
0.120
 Why?
National Heart, Lung, and Blood Institute (U.S.)
1
2015
101
0.110
 Why?
Fluticasone-Salmeterol Drug Combination
2
2012
8
0.110
 Why?
Carcinoma, Bronchogenic
1
2015
20
0.110
 Why?
Genomics
2
2018
832
0.110
 Why?
Referral and Consultation
1
2021
833
0.110
 Why?
Longitudinal Studies
6
2017
3013
0.110
 Why?
Graft Rejection
2
2013
551
0.110
 Why?
Overweight
2
2011
598
0.110
 Why?
Respiratory Tract Infections
2
2012
390
0.110
 Why?
Ambulatory Care Information Systems
2
2005
5
0.110
 Why?
Prednisolone
1
2014
68
0.100
 Why?
Postoperative Complications
2
2017
2912
0.100
 Why?
Telemedicine
1
2023
930
0.100
 Why?
Risk
4
2015
906
0.100
 Why?
Education, Medical, Continuing
2
2005
129
0.100
 Why?
Guideline Adherence
3
2020
575
0.100
 Why?
Environmental Exposure
3
2006
586
0.100
 Why?
Airway Obstruction
1
2015
167
0.100
 Why?
Forecasting
1
2015
384
0.100
 Why?
Bronchial Hyperreactivity
3
2010
102
0.100
 Why?
Transplantation
1
2013
33
0.100
 Why?
Quality Improvement
1
2022
1267
0.100
 Why?
Office Visits
4
2011
95
0.100
 Why?
Insurance Claim Review
1
2013
85
0.100
 Why?
Medicare
2
2022
810
0.090
 Why?
Peer Group
2
2012
251
0.090
 Why?
Growth
1
2012
52
0.090
 Why?
Double-Blind Method
5
2010
2021
0.090
 Why?
Costs and Cost Analysis
1
2013
220
0.090
 Why?
Cytomegalovirus Infections
2
2012
199
0.090
 Why?
Methacholine Chloride
3
2008
50
0.090
 Why?
Research
1
2015
439
0.090
 Why?
Metered Dose Inhalers
1
2012
13
0.090
 Why?
Cost of Illness
3
2003
319
0.090
 Why?
Feedback
1
2012
180
0.090
 Why?
Drug Dosage Calculations
1
2011
27
0.090
 Why?
Antibodies, Monoclonal, Humanized
2
2008
929
0.090
 Why?
Logistic Models
5
2017
2109
0.090
 Why?
Mycoses
1
2012
88
0.090
 Why?
Antifungal Agents
1
2012
149
0.090
 Why?
Effect Modifier, Epidemiologic
1
2011
9
0.090
 Why?
Multivariate Analysis
7
2017
1511
0.090
 Why?
Professional Role
1
2012
167
0.090
 Why?
Body Height
1
2012
208
0.090
 Why?
Morbidity
2
2022
321
0.090
 Why?
Medication Errors
1
2012
97
0.090
 Why?
Epidemiologic Studies
1
2011
68
0.080
 Why?
Mycobacterium
1
2012
112
0.080
 Why?
Obesity
3
2015
3046
0.080
 Why?
Pneumococcal Vaccines
1
2012
138
0.080
 Why?
Patient Readmission
1
2016
706
0.080
 Why?
Diagnostic Errors
1
2012
177
0.080
 Why?
Secondary Prevention
1
2012
241
0.080
 Why?
Drug Resistance
1
2011
153
0.080
 Why?
Program Development
1
2012
371
0.080
 Why?
Probability
1
2011
308
0.080
 Why?
Vitamin D Deficiency
1
2012
188
0.080
 Why?
Lung Diseases
1
2017
789
0.080
 Why?
Chi-Square Distribution
2
2017
527
0.080
 Why?
Bronchial Provocation Tests
2
2008
47
0.080
 Why?
Fluticasone
2
2008
56
0.080
 Why?
Decision Support Techniques
2
2012
445
0.080
 Why?
Pragmatic Clinical Trials as Topic
2
2020
132
0.080
 Why?
Incidence
5
2020
2854
0.080
 Why?
Receptors, Corticotropin-Releasing Hormone
1
2009
28
0.080
 Why?
Immunoglobulin E
2
2008
323
0.080
 Why?
Vital Capacity
4
2017
311
0.080
 Why?
Lectins, C-Type
1
2009
62
0.080
 Why?
Ambulatory Care
2
2011
601
0.070
 Why?
Algorithms
1
2017
1818
0.070
 Why?
Health Services
2
2007
116
0.070
 Why?
Proportional Hazards Models
1
2012
1294
0.070
 Why?
Odds Ratio
4
2017
1060
0.070
 Why?
Medication Therapy Management
1
2010
79
0.070
 Why?
Smoking
3
2017
1580
0.070
 Why?
Health Knowledge, Attitudes, Practice
2
2012
1414
0.070
 Why?
Pandemics
3
2022
1669
0.070
 Why?
Surgical Wound Infection
1
2012
329
0.070
 Why?
Acute Disease
1
2011
1015
0.070
 Why?
Kaplan-Meier Estimate
3
2016
923
0.070
 Why?
Vitamin K Epoxide Reductases
1
2008
11
0.070
 Why?
Cytochrome P-450 CYP2C9
1
2008
19
0.070
 Why?
Cross-Sectional Studies
6
2010
5762
0.070
 Why?
Eosinophil Cationic Protein
1
2008
9
0.070
 Why?
Mixed Function Oxygenases
1
2008
48
0.070
 Why?
Program Evaluation
1
2012
938
0.070
 Why?
Aryl Hydrocarbon Hydroxylases
1
2008
47
0.070
 Why?
Adrenergic beta-Agonists
1
2008
97
0.070
 Why?
Genetic Techniques
1
2008
67
0.070
 Why?
Quality-Adjusted Life Years
2
2006
113
0.070
 Why?
Trastuzumab
1
2008
102
0.070
 Why?
Insurance, Pharmaceutical Services
1
2008
24
0.070
 Why?
Markov Chains
2
2006
126
0.070
 Why?
State Health Plans
1
2008
33
0.070
 Why?
Cost Sharing
1
2008
20
0.070
 Why?
Smoking Cessation
1
2012
435
0.070
 Why?
Antibodies, Anti-Idiotypic
1
2007
50
0.070
 Why?
Reimbursement Mechanisms
1
2008
82
0.070
 Why?
Chronic Disease
3
2017
1834
0.070
 Why?
Omalizumab
1
2007
43
0.070
 Why?
Mycobacterium Infections, Nontuberculous
1
2012
367
0.070
 Why?
Exercise Tolerance
2
2022
285
0.070
 Why?
Factor Analysis, Statistical
1
2008
304
0.060
 Why?
Interviews as Topic
1
2011
872
0.060
 Why?
Warfarin
1
2008
168
0.060
 Why?
Health Surveys
2
2006
512
0.060
 Why?
Influenza Vaccines
1
2012
553
0.060
 Why?
Antiviral Agents
1
2012
763
0.060
 Why?
Databases, Factual
1
2012
1465
0.060
 Why?
Animals, Domestic
1
2006
16
0.060
 Why?
Lung Diseases, Interstitial
1
2013
658
0.060
 Why?
Tomography, X-Ray Computed
1
2017
2782
0.060
 Why?
Health Services Accessibility
2
2021
1061
0.060
 Why?
Animals
2
2025
38080
0.060
 Why?
Physicians, Family
2
2004
192
0.060
 Why?
Eosinophils
1
2008
325
0.060
 Why?
Biomedical Research
1
2012
699
0.060
 Why?
Health Benefit Plans, Employee
1
2005
27
0.060
 Why?
Database Management Systems
1
2005
51
0.060
 Why?
Hip Fractures
1
2006
85
0.060
 Why?
Models, Biological
1
2012
1831
0.050
 Why?
Health Policy
1
2008
395
0.050
 Why?
Patients
1
2006
180
0.050
 Why?
Insurance Coverage
1
2006
240
0.050
 Why?
Utilization Review
1
2004
41
0.050
 Why?
Infant
3
2008
10022
0.050
 Why?
Body Mass Index
3
2015
2432
0.050
 Why?
Patient Education as Topic
3
2005
783
0.050
 Why?
Gene Expression Profiling
1
2011
1794
0.050
 Why?
Medicaid
1
2008
460
0.050
 Why?
Clinical Competence
1
2012
1238
0.050
 Why?
Prenatal Exposure Delayed Effects
1
2010
680
0.050
 Why?
Nitric Oxide
1
2008
899
0.050
 Why?
Mass Screening
1
2012
1337
0.050
 Why?
Sex Factors
3
2016
2097
0.050
 Why?
Anticoagulants
1
2008
728
0.050
 Why?
Attitude to Health
1
2006
452
0.050
 Why?
Vaccination
1
2012
1483
0.050
 Why?
Case Management
1
2003
66
0.050
 Why?
Clinical Trials as Topic
2
2005
1044
0.050
 Why?
Puerto Rico
1
2022
54
0.050
 Why?
Choice Behavior
1
2004
173
0.050
 Why?
Anti-Bacterial Agents
2
2004
1911
0.050
 Why?
Parents
3
2006
1457
0.050
 Why?
Symptom Flare Up
1
2022
38
0.050
 Why?
Sputum
1
2004
313
0.040
 Why?
Circadian Rhythm
1
2006
514
0.040
 Why?
Academies and Institutes
1
2022
61
0.040
 Why?
Health Services Research
1
2004
402
0.040
 Why?
Lung Neoplasms
1
2015
2583
0.040
 Why?
Minority Groups
1
2003
279
0.040
 Why?
Survival Rate
2
2016
2008
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2020
76
0.040
 Why?
Electronics
1
2021
74
0.040
 Why?
Clinical Trials, Phase III as Topic
1
2020
114
0.040
 Why?
Efficiency
1
2021
101
0.040
 Why?
Sample Size
1
2020
126
0.040
 Why?
Health Care Reform
1
2021
109
0.040
 Why?
Schools, Medical
1
2021
158
0.040
 Why?
Risk Assessment
3
2020
3585
0.040
 Why?
Patient Selection
2
2020
692
0.040
 Why?
Language
1
2022
324
0.040
 Why?
Patient Compliance
2
2016
618
0.040
 Why?
Stress, Psychological
1
2007
1138
0.040
 Why?
Time
1
2019
87
0.040
 Why?
Cluster Analysis
2
2014
526
0.040
 Why?
Health Education
1
2002
362
0.040
 Why?
Quality of Health Care
1
2003
650
0.040
 Why?
Poland
1
2017
35
0.030
 Why?
Republic of Korea
1
2017
42
0.030
 Why?
Bronchitis, Chronic
1
2017
24
0.030
 Why?
Cooperative Behavior
1
2021
459
0.030
 Why?
Patient-Centered Care
1
2003
546
0.030
 Why?
Sensitivity and Specificity
3
2013
1986
0.030
 Why?
Nitrogen Dioxide
1
1997
49
0.030
 Why?
Geography
1
2018
202
0.030
 Why?
Aftercare
1
2019
218
0.030
 Why?
Long-Term Care
1
2018
111
0.030
 Why?
Monitoring, Physiologic
2
2012
289
0.030
 Why?
Self Concept
1
2019
257
0.030
 Why?
Netherlands
1
2016
86
0.030
 Why?
Antineoplastic Agents
1
2008
2195
0.030
 Why?
Pediatrics
1
2005
1127
0.030
 Why?
Tuberculosis, Pulmonary
1
2017
130
0.030
 Why?
Forced Expiratory Flow Rates
1
2015
10
0.030
 Why?
Formoterol Fumarate
1
2015
7
0.030
 Why?
Salmeterol Xinafoate
1
2015
22
0.030
 Why?
Ethanolamines
1
2015
15
0.030
 Why?
Perception
1
2019
378
0.030
 Why?
Receptors, Adrenergic, beta-2
1
2015
34
0.030
 Why?
Treatment Failure
1
2016
357
0.030
 Why?
Feasibility Studies
1
2020
1051
0.030
 Why?
Dose-Response Relationship, Drug
2
2011
2057
0.030
 Why?
Self Efficacy
1
2019
409
0.030
 Why?
Education
1
2015
107
0.030
 Why?
Postoperative Period
1
2016
361
0.030
 Why?
Polymorphism, Single Nucleotide
2
2016
2181
0.030
 Why?
Age Factors
3
2008
3331
0.030
 Why?
Fatal Outcome
1
2015
313
0.030
 Why?
Immunosuppressive Agents
2
2015
859
0.030
 Why?
Biopsy
2
2013
1083
0.030
 Why?
Pilot Projects
1
2020
1839
0.030
 Why?
Combined Modality Therapy
1
2017
1254
0.030
 Why?
Patient Acceptance of Health Care
1
2021
890
0.030
 Why?
Gene Expression
1
2018
1505
0.030
 Why?
Telephone
2
2005
181
0.020
 Why?
Echinocandins
1
2012
8
0.020
 Why?
Lipopeptides
1
2012
14
0.020
 Why?
Aspergillosis
1
2012
23
0.020
 Why?
Amphotericin B
1
2012
39
0.020
 Why?
Intention to Treat Analysis
1
2012
77
0.020
 Why?
Candidiasis
1
2012
63
0.020
 Why?
Tissue Donors
1
2015
412
0.020
 Why?
Transplantation, Homologous
1
2013
415
0.020
 Why?
Mycobacterium avium Complex
1
2012
88
0.020
 Why?
Age Distribution
2
2003
398
0.020
 Why?
Cromolyn Sodium
2
2001
5
0.020
 Why?
Hypoxia
1
2019
1191
0.020
 Why?
Leukotriene Antagonists
1
2011
24
0.020
 Why?
Extracorporeal Membrane Oxygenation
1
2015
361
0.020
 Why?
Triazoles
1
2012
168
0.020
 Why?
Self Care
2
2005
388
0.020
 Why?
Functional Residual Capacity
1
2010
7
0.020
 Why?
Reference Values
1
2012
811
0.020
 Why?
Costa Rica
1
2010
18
0.020
 Why?
Colorado
1
2021
4669
0.020
 Why?
Principal Component Analysis
1
2011
198
0.020
 Why?
Nontuberculous Mycobacteria
1
2012
209
0.020
 Why?
Health
1
2010
83
0.020
 Why?
Inhalation
1
2010
29
0.020
 Why?
Genome-Wide Association Study
1
2016
1452
0.020
 Why?
Environment
1
2011
344
0.020
 Why?
Observation
1
2008
56
0.020
 Why?
Sex Ratio
1
2008
15
0.020
 Why?
Least-Squares Analysis
1
2008
78
0.020
 Why?
Models, Econometric
1
2008
36
0.020
 Why?
Prospective Studies
2
2012
7918
0.020
 Why?
Health Services Administration
1
2007
8
0.020
 Why?
Treatment Refusal
1
2008
97
0.020
 Why?
Social Isolation
1
2007
66
0.020
 Why?
Intelligence
1
2007
135
0.020
 Why?
Puberty
1
2008
158
0.020
 Why?
Body Weight
1
2011
1003
0.020
 Why?
Child Behavior Disorders
1
2007
143
0.020
 Why?
Exercise
1
2016
2166
0.010
 Why?
CD4-Positive T-Lymphocytes
1
2011
1130
0.010
 Why?
Insurance, Health
1
2007
303
0.010
 Why?
Genotype
1
2009
1877
0.010
 Why?
Bronchoconstrictor Agents
1
2003
14
0.010
 Why?
Organizational Innovation
1
2004
128
0.010
 Why?
Health Status Indicators
1
2004
161
0.010
 Why?
Systems Integration
1
2003
38
0.010
 Why?
Case-Control Studies
1
2010
3634
0.010
 Why?
Computer Systems
1
2003
53
0.010
 Why?
Motor Activity
1
2007
721
0.010
 Why?
Self Disclosure
1
2002
66
0.010
 Why?
Histamine H1 Antagonists
1
2002
27
0.010
 Why?
Drug Administration Schedule
1
2004
774
0.010
 Why?
Child Welfare
1
2004
230
0.010
 Why?
Administration, Intranasal
1
2002
94
0.010
 Why?
Confidence Intervals
1
2002
332
0.010
 Why?
Regression Analysis
1
2003
1014
0.010
 Why?
Nurse's Role
1
2003
169
0.010
 Why?
Point-of-Care Systems
1
2003
190
0.010
 Why?
Health Care Surveys
1
2002
565
0.010
 Why?
Sex Distribution
1
2001
383
0.010
 Why?
Patient Satisfaction
1
2004
701
0.010
 Why?
Linear Models
1
2002
860
0.010
 Why?
Disease Management
1
2003
649
0.010
 Why?
Decision Support Systems, Clinical
1
2003
270
0.010
 Why?
Bronchoscopy
1
2000
227
0.010
 Why?
Caregivers
1
2007
971
0.010
 Why?
Internet
1
2003
697
0.010
 Why?
Pregnancy
1
2010
7169
0.010
 Why?
Survival Analysis
1
2000
1332
0.010
 Why?
Infant, Newborn
1
2004
6385
0.010
 Why?
Fuhlbrigge's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (429) concept(s)
_
Co-Authors Expand Description
See all (18) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)